DIFFERENTIATION OF MYELOID LEUKEMIC-CELLS INDUCED BY HIGH-DOSE METHYLPREDNISOLONE IN PATIENTS WITH ACUTE MYELOBLASTIC-LEUKEMIA AND ITS THERAPEUTIC POTENTIAL

被引：31
|
作者：
HICSONMEZ, G
OZSOYLU, S
TUNCER, AM
机构：
[1] Department of Pediatric Hematology, Hacettepe University, Faculty of Medicine
来源：
LEUKEMIA RESEARCH | 1991年 / 15卷 / 07期
关键词：
DIFFERENTIATION THERAPY; HIGH-DOSE METHYLPREDNISOLONE; ACUTE MYELOBLASTIC LEUKEMIA; CHILDREN;
D O I：
10.1016/0145-2126(91)90020-T
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：537 / 541
页数：5
相关论文
共 50 条
  • [31] High-dose cytarabine benefits patients with acute myeloid leukemia and RAS mutations
    不详
    Nature Clinical Practice Oncology, 2009, 6 (1): : 3 - 4
  • [32] Potential for therapy with leukemic dendritic cells derived from patients with acute myeloid leukemia
    Mohty, M
    Isnardon, D
    Blaise, D
    Brière, F
    Gastaut, JA
    Olive, D
    Gaugler, B
    BONE MARROW TRANSPLANTATION, 2002, 29 : S76 - S76
  • [33] Potential for therapy with leukemic dendritic cells derived from patients with acute myeloid leukemia
    Mohty, M
    Blaise, D
    Isnardon, D
    Olive, D
    Gaugler, B
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) : 89 - 89
  • [34] A FEASIBILITY STUDY OF HIGH-DOSE CYTOSINE-ARABINOSIDE (ARA-C) AS PRIMARY-TREATMENT OF ACUTE MYELOBLASTIC-LEUKEMIA (AML)
    CURTIS, JE
    MESSNER, HA
    MINDEN, MD
    MCCULLOCH, EA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 185 - 185
  • [35] A comparison of the effect of high-dose methylprednisolone with conventional-dose prednisolone in acute lymphoblastic leukemia patients with randomization
    Yetgin, S
    Gürgey, A
    Tuncer, AM
    Çetin, M
    Özbek, N
    Sayli, T
    Güler, E
    Kara, A
    Olcay, L
    Duru, F
    Gümrük, F
    Atahan, L
    Tunçbilek, E
    LEUKEMIA RESEARCH, 1998, 22 (06) : 485 - 493
  • [36] ANTI-LEUKEMIC EFFECT OF HIGH-DOSE THYMIDINE IN A RAT MODEL FOR ACUTE MYELOID-LEUKEMIA (BNML)
    SONNEVELD, P
    VANGELDER, TC
    VANBEKKUM, DW
    EUROPEAN JOURNAL OF CANCER, 1981, 17 (01) : 89 - 92
  • [37] MITOXANTRONE-INDUCED DNA DAMAGE IN LEUKEMIC-CELLS IS ENHANCED BY TREATMENT WITH HIGH-DOSE ARA-C
    HEINEMANN, V
    MURRAY, D
    ADAMS, T
    WALTERS, R
    MEYN, R
    PLUNKETT, W
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 118 - 118
  • [38] PART 1: THE ROLE OF MECHANORECEPTION IN CELL DIFFERENTIATION AND ITS THERAPEUTIC POTENTIAL IN ACUTE MYELOID LEUKEMIA
    Estevez Maria, Velasco
    Garrido Pedro, Aguilar
    Miguel Angel, Navarro Aguadero
    Vanessa, Garrido
    Alicia, Gimenez
    Laura, Moreno
    Esther, Gallardo
    Lopez Joaquin, Martinez
    Delgado Miguel, Gallardo
    HAEMATOLOGICA, 2021, 106 (10) : 84 - 84
  • [39] Outcome of Patients with Acute Myeloid Leukemia Treated with Salvage High-Dose Cytarabine Monotherapy
    Canaani, Jonathan
    Luskin, Marlise R.
    Loren, Alison
    Timlin, Colleen
    Mangan, James
    Hexner, Elizabeth O.
    Frey, Noelle V.
    Porter, David L.
    Stadtmauer, Edward A.
    Luger, Selina
    BLOOD, 2015, 126 (23)
  • [40] Toxicity of laromustine plus high-dose cytarabine in patients with relapsed acute myeloid leukemia
    Deisseroth, Albert
    Farrell, Ann
    Justice, Robert
    Kane, Robert
    Sridhara, Rajeshwari
    Chen, Huanyu
    He, Kun
    Pazdur, Richard
    BLOOD, 2010, 115 (02) : 430 - 430
12345